Your browser doesn't support javascript.
loading
Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience.
Dreger, Peter; Holtick, Udo; Subklewe, Marion; von Tresckow, Bastian; Ayuk, Francis; Wagner, Eva; Wulf, Gerald; Marks, Reinhardt; Penack, Olaf; Schnetzke, Ulf; Koenecke, Christian; von Bonin, Malte; Stelljes, Matthias; Glass, Bertram; Baldus, Claudia D; Vucinic, Vladan; Mougiakakos, Dimitrios; Topp, Max; Schroers, Roland; Wolff, Daniel; Thomas, Simone; Kröger, Nicolaus; Bethge, Wolfgang A.
Afiliación
  • Dreger P; University Hospital Heidelberg, Department of Hematology & Oncology, Heidelberg, Germany. peter.dreger@med.uni-heidelberg.de.
  • Holtick U; Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Subklewe M; University Hospital Munich (LMU Munich), Department of Hematology & Oncology, Munich, Germany.
  • von Tresckow B; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Ayuk F; University Hospital Hamburg, Department for Stem Cell Transplantation, Hamburg, Germany.
  • Wagner E; University Hospital Mainz, Department of Hematology & Oncology, Mainz, Germany.
  • Wulf G; University Medicine Goettingen, Clinic for Hematology & Medical Oncology, Göttingen, Germany.
  • Marks R; University Hospital Freiburg, Department of Hematology & Oncology, Freiburg, Germany.
  • Penack O; University Hospital Charite, Department of Hematology & Oncology, Berlin, Germany.
  • Schnetzke U; University Hospital Jena, Department of Hematology & Oncology, Jena, Germany.
  • Koenecke C; University Hospital Hannover, Department of Hematology & Oncology, Hannover, Germany.
  • von Bonin M; University Hospital Dresden, Department of Hematology & Oncology, Dresden, Germany.
  • Stelljes M; University Hospital Muenster, Department of Hematology & Oncology, Muenste, Germany.
  • Glass B; Klinikum Berlin-Buch, Department of Hematology & Oncology, Berlin, Germany.
  • Baldus CD; University Hospital Kiel, Department of Hematology & Oncology, Kiel, Germany.
  • Vucinic V; University Hospital Leipzig, Leipzig, Germany.
  • Mougiakakos D; University Hospital Erlangen, Department of Hematology & Oncology, Erlangen, currently University Hospital Magdeburg, Department of Hematology, Magdeburg, Germany.
  • Topp M; University Hospital Würzburg, Department of Hematology & Oncology, Würzburg, Germany.
  • Schroers R; University Hospital Bochum, Department of Hematology & Oncology, Bochum, Germany.
  • Wolff D; University Hospital Regensburg, Department ofInternal Medicine III, Hematology and Oncology, Regensburg, Germany.
  • Thomas S; University Hospital Regensburg, Department ofInternal Medicine III, Hematology and Oncology, Regensburg, Germany.
  • Kröger N; Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Bethge WA; University Hospital Hamburg, Department for Stem Cell Transplantation, Hamburg, Germany.
Bone Marrow Transplant ; 58(2): 229-232, 2023 02.
Article en En | MEDLINE | ID: mdl-36418916
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido